ARENSIA Exploratory Medicine S.R.L.

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Liver cirrhosis1 trial
• Melanoma1 trial

Phase

• Phase 12 trials

Status

• Completed2 trials

Lead sponsor

• Alentis Therapeutics AG1 trial
• Formycon AG1 trial

Closed trials

• Completed

  Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

  NCT06551064· Phase 1· Formycon AG· Source

• Completed

  A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis

  NCT05939947· Phase 1· Alentis Therapeutics AG· Source